Forte believes that participation in our clinical trials is the best way to access our investigational products. We encourage patients to consult with their healthcare providers and consider participation in one of these trials. To ensure we can produce a sufficient supply of our investigational products for ongoing clinical trial and development programs, Forte is not offering its investigational products through Expanded Access at this time. Our priority is to develop safe and effective therapies and make them available as quickly as possible to patients. We remain committed to evaluating expanded access as our programs progress.